Sign in
4

Changes in Ownership

SAB Biotherapeutics, Inc. Filed Acc 0001193125-25-226846

Director acquired 1,740,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Moin Andrew Director 2025-09-29 Option exercise +1,740,000 $1.75 $3,045,000 2,198,457 I: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Moin Andrew Director 2025-09-29 Option exercise · Series B Convertible Preferred Stock −17,400 211,100 I: show line 2 in the form
Loading xslF345X05/ownership.xml…